Esophageal Varices in Adolescent and Young Adult Males with Acute Lymphocytic Leukemia.

Hepatic late effects are not commonly reported in survivors of childhood leukemia. Four young male patients with acute lymphoblastic leukemia (ALL) were diagnosed with bleeding esophageal varices (EVs) during or shortly after completion of maintenance chemotherapy. EVs were identified from 0 to 60 months after completion of leukemia therapy. All four patients were men between 20 to 24 years old. Hematemesis was the most common presenting symptom. Associated features included splenomegaly, cytopenias, azole therapy, alcohol use, and hepatic iron overload. EVs may be an under-recognized complication of ALL therapy, with adolescent and young adult males at highest risk.

[1]  J. Olsen,et al.  Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population‐based cohort study , 2016, International journal of cancer.

[2]  J. Molleston,et al.  Screening and Prophylaxis for Varices in Children with Liver Disease , 2015, Current Gastroenterology Reports.

[3]  Karen A. Diefenbach,et al.  Survivors of childhood cancer have increased risk of gastrointestinal complications later in life. , 2011, Gastroenterology.

[4]  A. Bleyer,et al.  Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. , 2010, Blood.

[5]  Christian Urban,et al.  Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. , 2007, Blood.

[6]  M. De Vos,et al.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine , 2007, Gut.

[7]  F. Wrba,et al.  6-Thioguanine Associated Nodular Regenerative Hyperplasia in Patients With Inflammatory Bowel Disease May Induce Portal Hypertension , 2007, The American Journal of Gastroenterology.

[8]  M. Loh,et al.  Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). , 2007, Blood.

[9]  Angela E. Thomas,et al.  6-Thioguanine-related Chronic Hepatotoxicity and Variceal Haemorrhage in Children Treated for Acute Lymphoblastic Leukaemia-A Dual-centre Experience , 2006, Journal of pediatric gastroenterology and nutrition.

[10]  B. Portmann,et al.  Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. , 2006, Journal of hepatology.

[11]  R. Wong,et al.  Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6‐thioguanine during maintenance therapy , 2005, Pediatric blood & cancer.

[12]  V. Saha,et al.  Veno‐occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia , 2003, British journal of haematology.